Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates Sep 29, 2021
Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy Sep 21, 2021
Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its… Sep 20, 2021
Tim Schlidt of Palo Santo Discusses Why Psychedelics Therapy is the Future of End-of-Life Care Sep 13, 2021
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative… Aug 25, 2021
Strong Psychedelic Data In 1H 2021 Sets The Stage For Key Endpoint Results Later This Year Jun 23, 2021
